3D Endoanal Ultrasound and Anal Fistula

The study aims to evaluate the use of 3D endoanal ultrasound in preoperative management of anal fistula disease.

Completed

Looking for future studies?

Key information

Conditions

Anal Fistula Digestive System Diseases Digestive System Fistula Fistula Gastrointestinal Diseases Intestinal Diseases Intestinal Fistula Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Rectal Diseases Rectal Fistula

Sex eligibility

All sexes

Study type

Observational

Primary location

Pelvic Floor Centre

Malmö, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

anal fistula
no previous fistula procedures

Exclusion criteria

previous fistula procedures
ano/rectovaginal fistula
inflammatory bowel disease
more than one internal openings

Treatment and study plan

3D endodanal ultrasound

Other

Endoanal ultrasound performed with two different transducers preoperatively during a fistula treatment procedure.

Other names: 3D endoanal ultrasonography

Primary outcomes

Fistula position

Time frame: Day 1

Dorsal? Ventral? Lateral - right or left?
Fistula level

Time frame: Day 1

Level I-IV (how much of the sphincter is affected?)
Fistula length

Time frame: Day 1

Shorter or longer than 3 cm?

Sponsors and collaborators

Lead sponsor

Region Skane

Other

Registry information

Official study title

The Role of 3D Endoanal Ultrasound in Management of Anal Fistulas

Acronym: UFU

Important dates

Study start: 2018
Primary completion: 2020
Study completion: 2023
First posted: May 6, 2019
Registry last updated: Feb 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed